A strong focus on innovation and innovative investments

The research and development of new products and / or services, the investment is crucial to support and enhance their market presence.

Medilink is particularly active in R&D with a strong focus on innovation and innovative investments, consolidating a lot of experience in participation in the notices of access to EU funds for research and development. Medilink has ongoing relationships and consistent with research centers, universities and companies both nationally and internationally.

Over the last few years, it has presented and participated, as a technological partner or as a beneficiary, in multiple R&D projects, as part of the most important subsidy opportunities in recent years.

Medilink has accompanied many companies in the implementation of processes of technological innovation in sectors that are often very different, such as Health, Public Policy, Mobility, Communication, Energy, Tourism, realizing technical solutions and contributing significantly to the economic development of their customers.

The investment strategy adopted has allowed the creation of various proprietary solutions and the inclusion in market areas of certain interest for which industrial property rights are being developed.

Over the past few years, Medilink has developed considerable experience in research targeted at business combinations, such as enterprise networks, the development plans of the supply chain, the districts of technology and productivity, which are made in accordance with the new policies cohesion and sharing provided by the national strategic framework in response to the indication of the European community.

Here are some subsidized research projects currently being implemented

Medilink srl as Lead Partner
2020/2022. R&D project “SAFE-STRESS Active, Physiological and Ecological Safety for Stress” Id. 19 as part of the FCS – Ministerial Decree of 5 March 2018 – CHAPTER III – Counter procedure Research and development projects for application sectors consistent with the national strategy of intelligent specialization (SNSI) “Smart factory” and “Agrifood”. EPR partner IRIB-CNR, IFC-CNR.

Medilink srl as a Partner
2020/2022. R&D Project “METAMORFOSI – Methodologies, Applied Technologies and Research Models for an Operational Chain of Italian Silk” Cod. Id. 1829 under the FCS – Ministerial Decree 2 August 2019 – Negotiation procedure Research and development projects within the application sectors consistent with the National Strategy of Intelligent Specialization (SNSI) – Smart Factory. EPR partner IRIB-CNR.

Medilink srl as a Partner
2019/2022. R&D project “BrainHeart – Intelligent systems for the prevention of cardiovascular disease in the elderly through psychophysical well-being” Cod. 087490210350 as part of the P.O. FESR SICILY 2014/2020 Thematic Objective 1 – Research, Technological Development and Innovation, Specific Objective 1.1 – Increase in the innovation activity of companies – Public Notice of Action 1.1.5. Leader Euromed1 srl. EPR partner IRIB-CNR, IRCCS, UNIKORE.

Medilink srl as a Partner
2019/2022. R&D project “IR3MA PARKINSON CYCLONE IN LIFE (I: innovation, R3: rehabilitation – resonance – rtd fluxgate sensor, M: Multidisciplinary, A: Approach)” Code 088690110504 as part of the P.O. FESR SICILY 2014/2020 Thematic Objective 1 – Research, Technological Development and Innovation, Specific Objective 1.1 – Increase in the innovation activity of companies – Public Notice of Action 1.1.5. Lead Partner Diagnostics for images srl. EPR UNICT partner, IRCCS.

Medilink srl as a Partner
2019/2022. R&D project “LAB @ HOME – AN INTELLIGENT HOUSE FOR AUTISM” Cod. 08SR2620000204 as part of the P.O. FESR SICILY 2014/2020 Thematic Objective 1 – Research, Technological Development and Innovation, Specific Objective 1.1 – Increase in the innovation activity of companies – Public Notice of Action 1.1.5. Lead partner Vmcons srl. EPR partner IRIB-CNR, IRCCS.

Medilink srl as a Partner
2019/2022. R&D project “SALIRE: (Sound Algorithms for Low-latency Intelligent Recognition of Events)” Code 08CT2620000125 as part of the P.O. FESR SICILY 2014/2020 Thematic Objective 1 – Research, Technological Development and Innovation, Specific Objective 1.1 – Increase in the innovation activity of companies – Public Notice of Action 1.1.5. Lead partner Trilogic srl. EPR partner, UNICT.

Here are some subsidized research projects completed on schedule

Medilink srl as Lead Partner
2014/2016. R&D project “PRIORITY – platform for the implementation, management and distributed integration of services, data, models and innovative tools for early screening, analysis, personalization and monitoring of neurodevelopmental disorders”, Code PAC02L1_00247, CUP B78F13000460005, admitted to financing, under the DD Notice n. 436 of 13 March 2013 (STARTUP CALL), Directorial Decree n. 2711 of 13/12/2013 (1st classified in the ranking), together with the University of Messina and the CNR Institute of Clinical Physiology.

Medilink srl as Lead Partner
2016/2018. R&D project “SIVERAPP – System for rapid learning verification”.
Cod. F / 050135 / 01-02 / X32 as part of the Horizon 2020 – MISE program with the participation of UNIME.